Table 3.
Effect of asafoetida on hematological parameters by group
| Group | WBC (×103/µL) | RBC (×106/µL) | HB | HCT | PLT |
|---|---|---|---|---|---|
| Normal | 7.1±1.9 | 7.9±2.1 | 15±3.2 | 44±5.9 | 973±1.6 |
| PCOS | 6.2±1.1 | 7.2±2 | 14±2.9 | 41±4.8 | 1,037±18 |
| PCOS+asafoetida 12.5 mg/kg | 4.9±0.9 | 8±2.3 | 15±3.6 | 44±5.2 | 969±19 |
| PCOS+asafoetida 25 mg/kg | 5.2±1.6 | 7.6±1.9 | 15±3.8 | 42±4.8 | 982±17 |
| PCOS+asafoetida 50 mg/kg | 7±2.1 | 7±1.8 | 14±2.9 | 40±4.3 | 1,021±21 |
Values are presented as mean±standard error of the mean. Data were analyzed with analysis of variance followed by the Tukey test.
WBC, white blood cell; RBC, red blood cell; HB, hemoglobin; HCT, hematocrit; PLT, platelet; PCOS, polycystic ovary syndrome.